#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4482521	F	Agonist activity at PSGR/OR51E2 (unknown origin) expressed in human Hana3A cells co-transfected with CRE-Luc by luciferase reporter gene assay	Homo sapiens	24		cell-based format	Patent Bioactivity Data
2.	ALA4482522	F	Agonist activity at PSGR/OR51E2 (unknown origin) expressed in human Hana3A cells co-transfected with CRE-Luc by luciferase reporter gene assay relative to control 1 mM propionic acid	Homo sapiens	24		cell-based format	Patent Bioactivity Data
3.	ALA4482523	F	Antagonist activity at PSGR/OR51E2 (unknown origin) expressed in human Hana3A cells co-transfected with CRE-Luc by luciferase reporter gene assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
4.	ALA4482524	F	Antagonist activity at PSGR/OR51E2 (unknown origin) expressed in human Hana3A cells co-transfected with CRE-Luc assessed as reduction in 19-OH-AD-induced response by luciferase reporter gene assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
5.	ALA4482525	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of neuroendocrine trans-differentiation related gene expression by measuring increase in OR51E2 mRNA expression incubated for 12 days by RT-PCR analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA4482526	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of neuroendocrine trans-differentiation related gene expression by measuring increase in NSE mRNA expression incubated for 12 days by RT-PCR analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
7.	ALA4482527	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of neuroendocrine trans-differentiation related gene expression by measuring increase in AMACR mRNA expression incubated for 12 days by RT-PCR analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
8.	ALA4482528	B	Antagonist activity at PSGR/OR51E2 in human LNCaP cells assessed as suppression of neuroendocrine trans-differentiation related gene expression by measuring reduction in OR51E2 mRNA expression at 10 uM incubated for 3 days by RT-PCR analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
9.	ALA4482529	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring asparagine level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
10.	ALA4482530	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring glutaric acid level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
11.	ALA4482531	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring guanine level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
12.	ALA4482532	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring cysteine level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
13.	ALA4482533	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring alpha-ketoglutaric acid level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
14.	ALA4482534	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring 2-ketoleucine level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
15.	ALA4482535	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring hydroquinone level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA4482536	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring succinic acid level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
17.	ALA4482537	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring glyceric acid level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
18.	ALA4482538	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring n-acetylaspartic acid level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
19.	ALA4482539	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring hydroxyprolines level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data
20.	ALA4482540	B	Agonist activity at PSGR/OR51E2 in human LNCaP cells assessed as induction of change in extracellular metabolites level by measuring 2-deoxyglucose level at 100 nM incubated for 72 hrs by GC/MS analysis	Homo sapiens	1		cell-based format	Patent Bioactivity Data